HIPO Insider Sale: Stienstra Disposes 752 Shares at $36.97
Rhea-AI Filing Summary
Michael Stienstra, an officer of Hippo Holdings Inc. (HIPO), reported a change in beneficial ownership on a Form 4 related to a transaction dated 09/10/2025. The filing shows a disposition of 752 shares of Hippo common stock at a price of $36.97 each. After the reported transaction, Mr. Stienstra beneficially owns 77,644 shares, which the filing states includes 44,246 RSUs. The Form 4 was signed by an attorney-in-fact, Guy Zeltser, on 09/11/2025. No additional transactions, derivative holdings, or explanatory details beyond the RSU component are provided in the text.
Positive
- None.
Negative
- Insider disposition: The officer disposed of 752 shares of Hippo common stock at $36.97 on 09/10/2025.
- Concentration in RSUs: Of the 77,644 shares beneficially owned after the transaction, 44,246 are RSUs, indicating a large portion of holdings are restricted or awarded stock rather than freely tradable shares.
Insights
TL;DR: Officer sold a small number of shares; remaining holdings remain concentrated with a large RSU component.
The reported disposition of 752 shares at $36.97 is a modest transaction relative to the total reported beneficial holding of 77,644 shares. The filing discloses that 44,246 shares are RSUs, indicating a significant portion of the holdings are unvested or restricted equity awards rather than open-market purchases. The Form 4 includes no derivatives or additional sales, and the signature was executed by an attorney-in-fact. For investors, this is a routine insider sale disclosure rather than a material shift in ownership.
TL;DR: Governance disclosure is standard; sale was reported and filing identifies officer role and RSU exposure.
The Form 4 clearly identifies the reporting person as an officer (GM & Chief Insurance, HHIP) and provides the required transaction details: date (09/10/2025), quantity sold (752 shares), and price ($36.97). The filing also specifies post-transaction beneficial ownership of 77,644 shares including 44,246 RSUs, which is useful for assessing the mix of restricted compensation versus free trading stock. The document contains no indication of policy-based plans (e.g., Rule 10b5-1) or other governance notes.